Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

Add To Watchlist

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > a Scientist & CEO, 1 man CANNOT Master TWO SHIPS !!

View:

Post by SpaceLabs on Nov 09, 2021 10:30am

a Scientist & CEO, 1 man CANNOT Master TWO SHIPS !!

This is Common Sense and not Rocket Science Boiler Room'mates on BB,, who by their AGE predictions are Gaga!, GooGoo! ,DadaDada ,MaamaaMoomoo, figure it out.

More Dilution today by CEO at 30% discount to NY shareholders while we got a massive 1/12 rollback.
There is no need for further dilution by this Scientist who is a Failed CEO by all means.

Allen CEO needs to choose his ROLE. I suggest he should join the Scientific Board to advance the Med, let a SEASONED CEO in USA take the LEAD ROLE as CEO of XORTX !

196

Comment

Comment by Anklebiter42 on Nov 09, 2021 2:09pm

Spacelab, still trying to organize the C suite and BODs. Stick to your area of influence.......... fetch that cheeseburger and fries. Hold the relish. I thought you were off buying rat poison coins????

Comment

Comment by SpaceLabs on Nov 09, 2021 5:36pm

Newborn Anklebiter42 shows up with his TOE in his mouth. What I said was if we had a SEASONED CEO during this Nasdaq IPO, with his connections on Wall St Investment Firms, a large sum could have been raised over $10/shr. since we have only 13M after 1/12 rollback. Allen D'DoffD has no connections and appointed a RoadRunner Capital Firm to raise in the IPO at 30% discount at $4. This BOD has ...more

Comment

XORTX Therapeutics Inc